VERACYTE, INC. Revenue, Net (Deprecated 2018-01-31)
VERACYTE, INC. (VCYT) reported Revenue, Net (Deprecated 2018-01-31) of $22.75 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-07-23.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-07-23
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $22.75M, a 23.61% increase year-over-year.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $20.04M, a 21.96% increase year-over-year.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $19.60M, a 7.33% increase year-over-year.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $17.52M, a 5.83% decline year-over-year.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $71.95M, a 10.55% increase from fiscal 2016.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $65.08M, a 31.48% increase from fiscal 2015.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $49.50M, a 29.62% increase from fiscal 2014.
- VERACYTE, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $38.19M, a 74.51% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $22.75M 10-Q · filed 2018-07-23 | $42.79M 10-Q · filed 2018-07-23 | $62.39M derived: sum of 3 quarters · filed 2018-07-23 | $79.91M derived: sum of 4 quarters · filed 2018-07-23 |
| 2018-03-31 | $20.04M 10-Q · filed 2018-05-01 | $39.64M derived: sum of 2 quarters · filed 2018-05-01 | $57.16M derived: sum of 3 quarters · filed 2018-05-01 | $75.56M derived: sum of 4 quarters · filed 2018-07-23 |
| 2017-12-31 | $19.60M 10-K · filed 2018-02-27 | $37.12M derived: sum of 2 quarters · filed 2018-02-27 | $55.52M derived: sum of 3 quarters · filed 2018-07-23 | $71.95M 10-K · filed 2018-02-27 |
| 2017-09-30 | $17.52M 10-K · filed 2018-02-27 | $35.92M derived: sum of 2 quarters · filed 2018-07-23 | $52.36M 10-Q · filed 2017-11-07 | $70.61M derived: sum of 4 quarters · filed 2018-07-23 |
| 2017-06-30 | $18.41M 10-Q · filed 2018-07-23 | $34.84M 10-Q · filed 2018-07-23 | $53.09M derived: sum of 3 quarters · filed 2018-07-23 | $71.70M derived: sum of 4 quarters · filed 2018-07-23 |
| 2017-03-31 | $16.43M 10-Q · filed 2018-05-01 | $34.69M derived: sum of 2 quarters · filed 2018-05-01 | $53.29M derived: sum of 3 quarters · filed 2018-05-01 | $67.97M derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $18.26M 10-K · filed 2018-02-27 | $36.86M derived: sum of 2 quarters · filed 2018-02-27 | $51.53M derived: sum of 3 quarters · filed 2018-02-27 | $65.08M 10-K · filed 2018-02-27 |
| 2016-09-30 | $18.60M 10-K · filed 2018-02-27 | $33.28M derived: sum of 2 quarters · filed 2018-02-27 | $46.83M 10-Q · filed 2017-11-07 | $60.87M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $14.68M 10-K · filed 2018-02-27 | $28.23M 10-Q · filed 2017-07-31 | $42.27M derived: sum of 3 quarters · filed 2018-02-27 | $54.60M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $13.55M 10-K · filed 2018-02-27 | $27.59M derived: sum of 2 quarters · filed 2018-02-27 | $39.93M derived: sum of 3 quarters · filed 2018-02-27 | $51.84M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $14.04M 10-K · filed 2017-03-01 | $26.38M derived: sum of 2 quarters · filed 2017-03-01 | $38.28M derived: sum of 3 quarters · filed 2017-03-01 | $49.50M 10-K · filed 2018-02-27 |
| 2015-09-30 | $12.34M 10-K · filed 2017-03-01 | $24.24M derived: sum of 2 quarters · filed 2017-03-01 | $35.46M 10-Q · filed 2016-11-03 | $47.66M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $11.91M 10-K · filed 2017-03-01 | $23.13M 10-Q · filed 2016-08-03 | $35.33M derived: sum of 3 quarters · filed 2017-03-01 | $45.16M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $11.22M 10-K · filed 2017-03-01 | $23.42M derived: sum of 2 quarters · filed 2017-03-01 | $33.26M derived: sum of 3 quarters · filed 2017-03-01 | $41.93M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $12.20M 10-K · filed 2016-03-14 | $22.04M derived: sum of 2 quarters · filed 2016-03-14 | $30.71M derived: sum of 3 quarters · filed 2016-03-14 | $38.19M 10-K · filed 2017-03-01 |
| 2014-09-30 | $9.84M 10-K · filed 2016-03-14 | $18.52M derived: sum of 2 quarters · filed 2016-03-14 | $25.99M 10-Q · filed 2015-11-05 | $32.83M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $8.68M 10-K · filed 2016-03-14 | $16.15M 10-Q · filed 2015-08-13 | $22.99M derived: sum of 3 quarters · filed 2016-03-14 | $28.59M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $7.48M 10-K · filed 2016-03-14 | $14.31M derived: sum of 2 quarters · filed 2016-03-14 | $19.91M derived: sum of 3 quarters · filed 2016-03-14 | $24.98M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $6.84M 10-K · filed 2015-03-25 | $12.43M derived: sum of 2 quarters · filed 2015-03-25 | $17.50M derived: sum of 3 quarters · filed 2015-03-25 | $21.88M 10-K · filed 2016-03-14 |
| 2013-09-30 | $5.59M 10-K · filed 2015-03-25 | $10.66M derived: sum of 2 quarters · filed 2015-03-25 | $15.05M 10-Q · filed 2014-11-13 | $19.50M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | $5.07M 10-K · filed 2015-03-25 | $9.45M 10-Q · filed 2014-08-14 | $13.91M derived: sum of 3 quarters · filed 2015-03-25 | $17.13M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-03-31 | $4.38M 10-K · filed 2015-03-25 | $8.84M derived: sum of 2 quarters · filed 2015-03-25 | $12.06M derived: sum of 3 quarters · filed 2015-03-25 | $14.54M derived: sum of 4 quarters · filed 2015-03-25 |
| 2012-12-31 | $4.46M 10-K · filed 2014-03-20 | $7.68M derived: sum of 2 quarters · filed 2014-03-20 | $10.16M derived: sum of 3 quarters · filed 2014-03-20 | $11.63M 10-K · filed 2015-03-25 |
| 2012-09-30 | $3.22M 10-K · filed 2014-03-20 | $5.70M derived: sum of 2 quarters · filed 2014-03-20 | $7.17M 10-Q · filed 2013-11-25 | |
| 2012-06-30 | $2.48M 10-K · filed 2014-03-20 | $3.95M derived: sum of 2 quarters · filed 2014-03-20 | ||
| 2012-03-31 | $1.47M 10-K · filed 2014-03-20 | |||
| 2011-12-31 | $2.65M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |